RESHAPE LIFESCIENCES INC (RSLS) Stock News

USA - NASDAQ:RSLS - US76090R3093 - Common Stock

3.92 USD

+0.72 (+22.5%)

Last: 8/14/2025, 8:00:01 PM

3.22 USD

-0.7 (-17.86%)

After Hours: 8/14/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

RSLS Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Vyome Therapeutics, Inc. and ReShape Lifesciences Inc. - Mentions: HIND

Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

a month ago - By: Stocktwits

News Image

ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why

a month ago - By: Benzinga - Mentions: ARCT LIXT DERM EDIT ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

a month ago - By: ReShape Lifesciences

Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND

a month ago - By: Vyome Therapeutics and ReShape Lifesciences

Vyome Announces New Board of Directors with Deep MIT and AI Ties

a month ago - By: ReShape Lifesciences

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics

2 months ago - By: Benzinga - Mentions: AHG ONCO HCTI EKSO ...

12 Health Care Stocks Moving In Friday's After-Market Session

2 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders

2 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders

2 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit

2 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit

2 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025

2 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology

3 months ago - By: Stocktwits - Mentions: VXF

ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets

3 months ago - By: ReShape Lifesciences Inc

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets

3 months ago - By: Stocktwits - Mentions: VXF

ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism